XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
ATM Offering
Purchase Agreement
Series A Convertible Preferred Stock
Common Stock
Common Stock
ATM Offering
Common Stock
Purchase Agreement
Additional Paid-In Capital
Additional Paid-In Capital
ATM Offering
Additional Paid-In Capital
Purchase Agreement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2020 $ 14,484,660     $ 24 $ 5,200     $ 205,661,999     $ 5,298 $ (191,187,861)
Balance, shares at Dec. 31, 2020       23,770 5,199,997              
Stock-based compensation expense 337,823             337,823        
Release of restricted stock awards 1       $ 1              
Release of restricted stock awards, shares         1,390              
Net share settlement of restricted stock awards (1,197)             (1,197)        
Net share settlement of restricted stock award, shares         (250)              
Employee stock purchase plan expense 13,115             13,115        
Issuance of common stock   $ 6,855,198       $ 1,058     $ 6,854,140      
Issuance of common stock, shares           1,058,045            
Exercise of stock options 326             326        
Exercise of stock options, shares         75              
Net loss (4,848,307)                     (4,848,307)
Foreign currency translation adjustment (1,557)                   (1,557)  
Balance at Mar. 31, 2021 16,840,062     $ 24 $ 6,259     212,866,206     3,741 (196,036,168)
Balance, shares at Mar. 31, 2021       23,770 6,259,257              
Balance at Dec. 31, 2021 10,399,824     $ 24 $ 7,588     218,723,349     1,894 (208,333,031)
Balance, shares at Dec. 31, 2021       23,770 7,588,085              
Stock-based compensation expense 251,214             251,214        
Release of restricted stock awards         $ 4     (4)        
Release of restricted stock awards, shares         4,148              
Net share settlement of restricted stock awards (8,129)       $ (1)     (8,128)        
Net share settlement of restricted stock award, shares         (1,500)              
Employee stock purchase plan expense 16,591             16,591        
Issuance of common stock     $ 7,108,786       $ 834     $ 7,107,952    
Issuance of common stock, shares             834,054          
Conversion of Series A convertible preferred stock for common stock       $ (24) $ 158     (134)        
Conversion of Series A convertible preferred stock for common stock, shares       (23,770) 158,466              
Net loss (6,497,519)                     (6,497,519)
Foreign currency translation adjustment (2,293)                   (2,293)  
Balance at Mar. 31, 2022 $ 11,268,474       $ 8,583     $ 226,090,840     $ (399) $ (214,830,550)
Balance, shares at Mar. 31, 2022         8,583,253